Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.01 - Poster Session 1 - Cancer Biology
- Type: Poster Session
- Track: Biology
- Presentations: 27
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.01-005 - EGFR and KRAS mutations in patients having lung adenocarcinoma associated with human papilloma virus infection
10:26 - 10:40 | Author(s): A.F. Cardona
- Abstract
Loading...
-
+
P1.02 - Poster Session 1 - Novel Cancer Genes and Pathways
- Type: Poster Session
- Track: Biology
- Presentations: 22
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.02-014 - The Gene-Expression Profiles in advanced lung Adenocarcinoma associated with Wood Smoke or tobbacco exposure are different in brain metastasis
09:30 - 09:30 | Author(s): A.O. Gomez
- Abstract
Loading...
-
+
P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 59
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.06-019 - Common and uncommon EGFR mutations and their impact on response to EGFR tyrosine-kinase inhibitors and platinum-based chemotherapy in non-small cell lung cancer (NSCLC): Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)
09:30 - 09:30 | Author(s): O. Arrieta
- Abstract
Loading... -
+
P1.06-042 - Klotho expression in patients having EGFR mutations (CLICaP study)
09:30 - 09:30 | Author(s): C. Vargas
- Abstract
Loading... -
+
P1.06-046 - Prognostic Relevance of the Quantification of Circulating Tumor Cells by mean Epithelial Markers in Advanced Non-Small Cell Lung Cancer Patients.
09:30 - 09:30 | Author(s): S. Muniz-Hernandez
- Abstract
Loading...
-
+
P1.10 - Poster Session 1 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 57
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.10-054 - Reduction levels of Carcinoembryonic antigen as a predictive factor of response to chemotherapy in lung cancer patients with Advanced Non-small-cell lung cancer.
09:30 - 09:30 | Author(s): O. Arrieta
- Abstract
Loading...
-
+
P1.16 - Poster Session 1 - Other Thoracic Malignancies
- Type: Poster Session
- Track: Thymoma & Other Thoracic Malignancies
- Presentations: 4
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.16-004 - Pleural Solitary Fibrous Tumor: a case series
09:30 - 09:30 | Author(s): H. Vidrio-Morgado
- Abstract
Loading...
-
+
P1.23 - Poster Session 1 - Tobacco Control, Prevention and Chemoprevention
- Type: Poster Session
- Track: Prevention & Epidemiology
- Presentations: 3
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.23-003 - Health care costs of patients with Non Small Cell Lung Cancer related to smoking in the National Cancer Institute of Mexico
09:30 - 09:30 | Author(s): O. Arrieta
- Abstract
Loading...
-
+
MO10 - Molecular Pathology II
- Type: Mini Oral Abstract Session
- Track: Pathology
- Presentations: 13
- Moderators:W.A. Franklin
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside 104, Level 1
-
+
MO10.02 - Update genotyping non-small cell lung cancer (NSCLC) in Latin America: Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)
16:20 - 16:25 | Author(s): G. Bramuglia
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.10 - Poster Session 2 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.10-043 - Phase II study of biweekly irinotecan plus bevacizumab in heavily treated advanced non-small cell lung cancer (NSCLC)
09:30 - 09:30 | Author(s): A.F. Cardona
- Abstract
Loading...
-
+
P2.11 - Poster Session 2 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 46
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.11-048 - Nutritional status, body surface and sarcopenia are associated to dose reduction and severe gastrointestinal toxicity related to afatinib in patients with advanced NSCLC
09:30 - 09:30 | Author(s): O. Arrieta
- Abstract
Loading...
-
+
P2.18 - Poster Session 2 - Pathology
- Type: Poster Session
- Track: Pathology
- Presentations: 23
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.18-023 - Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced-disease non-small cell lung cancer.
09:30 - 09:30 | Author(s): A.D. Campos Parra
- Abstract
Loading...
